2015 American Transplant Congress
Age-Specific Graft Failure Rates in Pediatric Heart Transplant Recipients
Graft failure risk has been shown to peak during emerging adulthood (18-25 y) among kidney transplant recipients. The association between age and graft failure risk…2015 American Transplant Congress
Improving Latent Tuberculosis Diagnosis Before Kidney Transplantation in a Developing Country
Introduction: Tuberculosis has shown to be a great challenge in kidney transplantation, specially in developing countries due to the difficulties in diagnosis and treatment, leading…2015 American Transplant Congress
Mesenchymal Stem Cells Prevent Cold Ischemia-Reperfusion Injury in Lung Transplants
Background: Cold ischemia-reperfusion injury (IRI) is a major cause of graft failure in lung transplantation. Despite therapeutic benefits of mesenchymal stem cells (MSCs) in attenuating…2015 American Transplant Congress
Human Gingival Tissue-Derived Mesenchymal Stem Cells Reduce Murine Acute GVHD Via Killing of Effector CD8+ Cells Through CD39/Adenosine A1R and A2BR Pathways
Human gingival tissue-derived mesenchymal stem cells (GMSCs) are a convenient source of MSCs that have been shown to treat autoimmune disease. Here we use human…2015 American Transplant Congress
Comparison of Pharmacokinetics and Pharmacogenomics of Once-Daily Extended-Release MeltDose® Tacrolimus Tablets (Envarsus® XR) Vs. Twice-Daily Tacrolimus Capsules in Stable African American Kidney Transplant Patients: A Randomized Cross-Over Study
The CYP3A5 genotype is the most significant genetic factor impacting tacrolimus (tac) metabolism; expresser's of this genotype require higher tac doses to achieve therapeutic tac…2015 American Transplant Congress
Establishment of a Novel Model for Hypothermic Machine Perfusion In Vivo in Rabbits
Background: Hypothermic machine perfusion (MP) could improve outcome after transplantation of DCD kidneys, but protective mechanisms of MP remain largely unknown. Therefore, this study aims…2015 American Transplant Congress
Post-Kidney Allograft Nephrectomy Anti-HLA Immunization Is Not Due to a Release of Anti-HLA Antibodies from the Failed Kidney
Background and aims: The reasons for the increased incidence of de novo anti-HLA donor specific antibodies (DSAs) that is observed after kidney allograft nephrectomy (NTx)…2015 American Transplant Congress
Can the Need for Graft Nephrectomy After Late Renal Transplant Failure Be Predicted?
Nephrology, Radboud University Medical Centre, Nijmegen, Netherlands.
Introduction: Graft nephrectomy is universally recommended when graft survival is less than 6 months. In case of later graft failure it is not always necessary…2015 American Transplant Congress
Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases
1Transplantation, Mayo Clinic, Jacksonville, FL; 2Florida State University, Tallahassee, FL.
Background: Renal dysfunction in liver (LT) and liver-kidney (LKT) transplant candidates increases intraoperative risks of electrolyte disturbances and volume excess complications. The role of intraoperative…2015 American Transplant Congress
Technical Aspects of Reconstruction of Middle Hepatic Vein and Multiple Inferior Right Hepatic Veins Using Dual Artificial Vascular Grafts in Right Lobe Living Donor Liver Transplantation: “V-Plasty” Technique for Common Outflow Reconstruction Vs Second IVC Anastomosis
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Background:Presence of multiple inferior right hepatic veins (IRHV) along with undrained median sector pose technical difficulties in right lobe living donor liver transplantation (LDLT). Several…
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 170
- Next Page »